1. Home
  2. GAB vs OGN Comparison

GAB vs OGN Comparison

Compare GAB & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gabelli Equity Trust Inc. (The)

GAB

Gabelli Equity Trust Inc. (The)

N/A

Current Price

$5.62

Market Cap

1.8B

Sector

Finance

ML Signal

N/A

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.76

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GAB
OGN
Founded
1986
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
GAB
OGN
Price
$5.62
$13.76
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
$11.40
AVG Volume (30 Days)
666.2K
2.8M
Earning Date
01-01-0001
05-07-2026
Dividend Yield
10.91%
0.60%
EPS Growth
N/A
N/A
EPS
N/A
0.95
Revenue
N/A
$6,216,000,000.00
Revenue This Year
N/A
$0.45
Revenue Next Year
N/A
$1.67
P/E Ratio
N/A
$14.48
Revenue Growth
N/A
N/A
52 Week Low
$5.28
$5.69
52 Week High
$6.37
$13.77

Technical Indicators

Market Signals
Indicator
GAB
OGN
Relative Strength Index (RSI) 44.33 72.77
Support Level $5.60 $13.46
Resistance Level $5.72 N/A
Average True Range (ATR) 0.06 0.03
MACD -0.01 -0.00
Stochastic Oscillator 6.00 80.00

Price Performance

Historical Comparison
GAB
OGN

About GAB Gabelli Equity Trust Inc. (The)

Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: